Jiangsu Hengrui Medicine Co Ltd 276-SZ:Shanghai Stock Exchange

*Data is delayed | CNY
Last | 3:00 PM CTT
69.51quote price arrow down-1.93 (-2.70%)
Volume
45,286,231
52 week range
65.01 - 97.39

...

Loading . . .
  • Open71.20
  • Day High71.20
  • Day Low69.11
  • Prev Close71.44
  • 52 Week High97.39
  • 52 Week High Date01/08/21
  • 52 Week Low65.01
  • 52 Week Low Date05/10/21

Key Stats

  • Market Cap70,371.58M
  • Shares Out6,356.36M
  • 10 Day Average Volume37.51M
  • Dividend0.17
  • Dividend Yield0.24%
  • Beta
  • YTD % Change-25.16

KEY STATS

  • Open71.20
  • Day High71.20
  • Day Low69.11
  • Prev Close71.44
  • 52 Week High97.39
  • 52 Week High Date01/08/21
  • 52 Week Low65.01
  • 52 Week Low Date05/10/21
  • Market Cap70,371.58M
  • Shares Out6,356.36M
  • 10 Day Average Volume37.51M
  • Dividend0.17
  • Dividend Yield0.24%
  • Beta
  • YTD % Change-25.16

RATIOS/PROFITABILITY

  • EPS (TTM)1.02
  • P/E (TTM)68.11
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Jiangsu Hengrui Medicine Co Ltd

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
JIANSU HENGRUI MEDICINE CO., LTD. is a China-based company, principally engaged in the manufacture and distribution of pharmaceutical tablets, injections and raw materials. The Company's main products portfolio consists of antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents, antibiotics, specialty infusions and others. The Company distributes its products within domestic market and to overseas markets.
Yunshu Zhou
Chairman
Song Zhou
Chief Financial Officer
Address
No.7 Kunlunshan Road
Lianyungang Eco & Tech Development Zone
Lianyungang, JNG
222000
China